AbstractSimian–human immunodeficiency virus encoding both reverse transcriptase (RT) and envelope genes of HIV-1 (RT Env SHIV) is important for evaluating biomedical prevention modalities for HIV/AIDS. We describe virological characterization of a clade B RT Env SHIV following infection of macaques via multiple routes. In vivo passage of the RT Env SHIV through Indian rhesus macaque enhanced infectivity. Expanded virus had minimal envelope heterogeneity and was inhibited by NNRTIs and CCR5 antagonists. Infection of macaques with RT Env SHIV via mucosal or intravenous routes resulted in stable infection accompanied by peak plasma viremia of approximately 5×106 copies/ml that was controlled beyond set point. Molecular homogeneity of the virus...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...
Abstract Background Infection of nonhuman primates with simian immunodeficiency virus (SIV) or chime...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...
AbstractSimian–human immunodeficiency virus encoding both reverse transcriptase (RT) and envelope ge...
Abstract Background Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important catego...
AbstractThe use of HIV-1env/SIVmacchimeric viruses expressing divergent HIV-1 envelopes of clinical ...
Background: New simian–human immunodeficiency chimeric viruses with an HIV-1 env (SHIVenv) are criti...
Antiviral resistance is a significant obstacle in the treatment of human immunodeficiency virus type...
AbstractA new simian-human immunodeficiency virus (SHIV), carrying env from an uncloned HIV-1 subtyp...
AbstractThe immunogenicity of a polyvalent HIV-1 vaccine comprised of Env antigens from primary R5 i...
AbstractChimeric primate lentiviruses composed of SIV and HIV genes may allow the analysis of the ro...
RT-SHIV is a chimera of simian immunodeficiency virus (SIV) containing the reverse transcriptase (RT...
The availability of an effective vaginal microbicide would be a major step toward containment of HIV...
The availability of an effective vaginal microbicide would be a major step toward containment of HIV...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...
Abstract Background Infection of nonhuman primates with simian immunodeficiency virus (SIV) or chime...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...
AbstractSimian–human immunodeficiency virus encoding both reverse transcriptase (RT) and envelope ge...
Abstract Background Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are an important catego...
AbstractThe use of HIV-1env/SIVmacchimeric viruses expressing divergent HIV-1 envelopes of clinical ...
Background: New simian–human immunodeficiency chimeric viruses with an HIV-1 env (SHIVenv) are criti...
Antiviral resistance is a significant obstacle in the treatment of human immunodeficiency virus type...
AbstractA new simian-human immunodeficiency virus (SHIV), carrying env from an uncloned HIV-1 subtyp...
AbstractThe immunogenicity of a polyvalent HIV-1 vaccine comprised of Env antigens from primary R5 i...
AbstractChimeric primate lentiviruses composed of SIV and HIV genes may allow the analysis of the ro...
RT-SHIV is a chimera of simian immunodeficiency virus (SIV) containing the reverse transcriptase (RT...
The availability of an effective vaginal microbicide would be a major step toward containment of HIV...
The availability of an effective vaginal microbicide would be a major step toward containment of HIV...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...
Abstract Background Infection of nonhuman primates with simian immunodeficiency virus (SIV) or chime...
Human immunodeficiency virus type 1 (HIV-1) clade C causes \u3e50% of all HIV infections worldwide, ...